| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maia Biotechnology, Inc. (MAIA) has 9 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. MAIA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.52M | $2.16M | - | |
| CEO | 976.1K | $1.39M | - | |
| Other | 60.0K | $85.2K | - | |
| Other | 46.5K | $66.0K | - | |
| Dir | 29.8K | $42.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2023 | Louie Ngar Yee52 | Director | Buy | 48,000 | $2.25 | $108,000.00 | +5.2% | -0.8% | +23.0% | |
| Apr 27, 2023 | Guerrero Ramiro | Director | Buy | 8,500 | $2.25 | $19,125.00 | +2.8% | -0.8% | +23.0% | |
| Apr 20, 2023 | Smith Stan | Director | Buy | 10,000 | $3.74 | $37,400.00 | +1.8% | -31.7% | -39.1% | |
| Apr 18, 2023 | Guerrero Ramiro | Director | Buy | 1,263 | $4.17 | $5,266.71 | +0.4% | -40.7% | -47.3% | |
| Apr 17, 2023 | Luput Cristian | Director | Buy | 1,576 | $3.69 | $5,815.44 | +0.5% | -41.6% | -46.1% | |
| Apr 14, 2023 | Luput Cristian | Director | Buy | 1,424 | $3.60 | $5,122.80 | +0.2% | -39.4% | -38.8% | |
| Apr 4, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 2,300 | $3.52 | $8,105.50 | +0.1% | -38.2% | -33.9% | |
| Mar 31, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 1,700 | $3.46 | $5,875.85 | +0.1% | -37.9% | -28.3% | |
| Mar 24, 2023 | Smith Stan | Director | Buy | 938 | $3.49 | $3,273.62 | +0.2% | -38.1% | -40.4% | |
| Mar 23, 2023 | Smith Stan | Director | Buy | 3,320 | $3.32 | $11,023.10 | +0.3% | -29.3% | -31.3% |